Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

In Allergan USA, Inc. et al., v. MSN Laboratories Private Ltd., et al., the United States Court of Appeals for the Federal Circuit issued a precedential decision relating to obviousness-type double ...

The San Antonio, Texas-based company said it has found a way to use donor tissue for nipple reconstruction following a ...

The stock of eyecare company Bausch + Lomb Corp. was up 14%on Monday, after the Financial Times reported that the company is considering selling itself as a way to extricate itself from its indebted ...

On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware’s application of the ...

Details of the settlement between Baltimore and Johnson & Johnson remain secret, unlike previous opioid settlements that the ...

Given its better valuation, we believe that Pfizer stock (NYSE: PFE) is currently a better pick than its industry peer – AbbVie stock (NYSE:ABBV). PFE stock trades at a much lower multiple of 11x ...

In comparison, at its current levels of around $195, AbbVie stock trades at 18x expected 2024 earnings of $10.88 per share. This compares with the 12x average P/E multiple for ABBV seen over the last ...

Baltimore will begin a much-anticipated trial against drug companies to assign blame for the city’s opioid overdose death ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The city of Baltimore has reached a settlement with Walgreens, leaving three remaining defendants in the city’s ongoing ...